Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Intravenous Busulfan Plus Melphalan Is a Highly Effective, Non-Toxic Preparative Regimen for Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Lymphoid Malignancies.

Partow Kebriaei, MD, Timothy Madden, BS, PHARMD, Reza Kazerooni, RPH, Elizabeth Shpall, MD, Xuemei Wang, MS, Peter Thall, MD, Chitra Hosing, MD, Muzaffar Qazilbash, MD, Uday Popat, MD, Celina Ledesma, BS, Issa Khouri, MD, Richard Champlin, MD, Roy Jones, MD, Borje S. Andersson, MD

Blood (2009) 114 (22): 3415.

https://doi.org/10.1182/blood.V114.22.3415.3415

Published: 2009

Journal Articles

Addition of Umbilical Cord Blood (UCB) Unit to Reduced Intensity Conditioning (RIC) Regimen to Augment Graft Versus Tumor (GVT) in Patients (pts) with Advanced Hematologic Malignancies

Partow Kebriaei, MD, Sergio Giralt, MD, Dan Jones, MD, PhD, Karla Gutierrez, MPH, BS, Marcos De Lima, MD, Martin Korbling, MD, Issa F. Khouri, MD, Uday Popat, MD, Muzaffar H. Qazilbash, MD, Amin Alousi, MD, Stefan O Ciurea, MD, Laurence Cooper, MD, PhD, Elizabeth Shpall, MD, Richard Champlin, MD

Blood (2008) 112 (11): 3297.

https://doi.org/10.1182/blood.V112.11.3297.3297

Published: 2008

Journal Articles

Pre Transplant Values of C Reactive Protein (CRP) and Brain Natriuretic Peptide (BNP) as Predictors of Transplant Outcomes in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndromes (AML/MDS) Undergoing Allogeneic Stem Cell Transplantation (AlloSCT).

Blood (2007) 110 (11): 1984.

https://doi.org/10.1182/blood.V110.11.1984.1984

Published: 2007

Journal Articles

Efficacy of Azacytidine (5-AC) Given as Maintenance or Salvage Therapy for Patients (pts) with Acute Leukemia Post Allogeneic Stem Cell Transplantation (HSCT).

Elias Jabbour, MD, Sergio Giralt, MD, Hagop Kantarjian, MD, Guillermo Garcia-Manero, MD, Elizabeth Shpall, MD, Patrow Kebriaei, MD, Leandro de Padua, MD, Richard Champlin, MD, Marcos de Lima, MD

Blood (2007) 110 (11): 3013.

https://doi.org/10.1182/blood.V110.11.3013.3013

Published: 2007

Journal Articles

Nonmyeloablative Allogeneic Transplantation in the Imatinib Era: Three Chances To Achieve Molecular Remission in CML.

Richard E. Champlin, MD, Sergio Giralt, MD, Elizabeth Shpall, MD, Partow Kebriaei, MD, Paolo Anderlini, MD, Muzaffar Qazilbash, MD, John McMannis, PhD, Gloria McCormick, RN, Tobi Fisher, PA, Marcos de Lima, MD, Gabriela Rondon, MD

Blood (2007) 110 (11): 1028.

https://doi.org/10.1182/blood.V110.11.1028.1028

Published: 2007

Journal Articles

Umbilical Cord Blood Cells Express mRNA for Neuronal Genes MAP2 and NEFL.

Martin Korbling, MD, Wei Zhang, PhD, David Cogdell, PhD, James Reuben, MD, Hui Gao, PhD, Dongxia Xing, PhD, Ruth Katz, MD, Kawah Chan, MD, Elizabeth Shpall, MD

Blood (2006) 108 (11): 5154.

https://doi.org/10.1182/blood.V108.11.5154.5154

Published: 2006

Journal Articles

Optimizing Immunotherapy in Multiple Myeloma: Restoring the Function of Patient’s Monocyte-Derived Dendritic Cells by Inhibiting p38 or Activating MEK/ERK MAPK and Neutralizing Interleukin-6 in the Progenitor Cells.

Qing Yi, MD, PhD, Siqing Wang, MD, Sungyoul Hong, PhD, Jing Yang, PhD, Jianfei Qian, PhD, Xiang Zhang, MS, Elizabeth Shpall, MD, Larry W. Kwak, MD, PhD

Blood (2006) 108 (11): 3701.

https://doi.org/10.1182/blood.V108.11.3701.3701

Published: 2006

NARROW

Intravenous Busulfan Plus Melphalan Is a Highly Effective, Non-Toxic Preparative Regimen for Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Lymphoid Malignancies.

Addition of Umbilical Cord Blood (UCB) Unit to Reduced Intensity Conditioning (RIC) Regimen to Augment Graft Versus Tumor (GVT) in Patients (pts) with Advanced Hematologic Malignancies

Pre Transplant Values of C Reactive Protein (CRP) and Brain Natriuretic Peptide (BNP) as Predictors of Transplant Outcomes in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndromes (AML/MDS) Undergoing Allogeneic Stem Cell Transplantation (AlloSCT).

Efficacy of Azacytidine (5-AC) Given as Maintenance or Salvage Therapy for Patients (pts) with Acute Leukemia Post Allogeneic Stem Cell Transplantation (HSCT).

Nonmyeloablative Allogeneic Transplantation in the Imatinib Era: Three Chances To Achieve Molecular Remission in CML.

Umbilical Cord Blood Cells Express mRNA for Neuronal Genes MAP2 and NEFL.

Optimizing Immunotherapy in Multiple Myeloma: Restoring the Function of Patient’s Monocyte-Derived Dendritic Cells by Inhibiting p38 or Activating MEK/ERK MAPK and Neutralizing Interleukin-6 in the Progenitor Cells.

Email alerts

ASH Publications

American Society of Hematology

Intravenous Busulfan Plus Melphalan Is a Highly Effective, Non-Toxic Preparative Regimen for Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Lymphoid Malignancies.

Addition of Umbilical Cord Blood (UCB) Unit to Reduced Intensity Conditioning (RIC) Regimen to Augment Graft Versus Tumor (GVT) in Patients (pts) with Advanced Hematologic Malignancies

Pre Transplant Values of C Reactive Protein (CRP) and Brain Natriuretic Peptide (BNP) as Predictors of Transplant Outcomes in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndromes (AML/MDS) Undergoing Allogeneic Stem Cell Transplantation (AlloSCT).

Efficacy of Azacytidine (5-AC) Given as Maintenance or Salvage Therapy for Patients (pts) with Acute Leukemia Post Allogeneic Stem Cell Transplantation (HSCT).

Nonmyeloablative Allogeneic Transplantation in the Imatinib Era: Three Chances To Achieve Molecular Remission in CML.

Umbilical Cord Blood Cells Express mRNA for Neuronal Genes MAP2 and NEFL.

Optimizing Immunotherapy in Multiple Myeloma: Restoring the Function of Patient’s Monocyte-Derived Dendritic Cells by Inhibiting p38 or Activating MEK/ERK MAPK and Neutralizing Interleukin-6 in the Progenitor Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only